Protein aggregation and fibrillogenesis in cerebral and systemic amyloid disease

Protein aggregation and fibrillogenesis in cerebral and systemic amyloid disease

Introduction and technical survey: Protein aggregation and fibrillogenesisFibril formation by short synthetic peptidesIn vitrooligomerization and fibrillogenesis of amyloid-beta peptidesTau fibrillogenesisPrion protein aggregation and fibrillogenesisin vitroAlpha-synuclein aggregation and modulating...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: Harris, J. Robin (BerichterstatterIn)
Format: UnknownFormat
Sprache:eng
Veröffentlicht: Dordrecht u.a. Springer 2012
Schriftenreihe:Subcellular biochemistry 65
Schlagworte:
Amyloid beta-protein > Aggregation (Chemistry) > Amyloidosis > Proteins > physiopathology > Amyloid > Cell Aggregation > Plague, Amyloid > Protein Folding > Fibrillogenese > Hirnschädigung > Amyloidose
Online Zugang:Inhaltsverzeichnis
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction and technical survey: Protein aggregation and fibrillogenesisFibril formation by short synthetic peptidesIn vitrooligomerization and fibrillogenesis of amyloid-beta peptidesTau fibrillogenesisPrion protein aggregation and fibrillogenesisin vitroAlpha-synuclein aggregation and modulating factorsPathological self-aggregation of [beta](2)-microglobulin: A challenge for protein biophysicsIslet amyloid polypeptide: Aggregation and fibrillogenesisin vitroand its inhibitionMechanisms of transthyretin aggregation and toxicityFibrillogenesis of huntingtin and other glutamine containing proteinsAggregation and fibrillogenesis of proteins not associated with disease: a few case studiesExperimental inhibition of peptide fibrillogenesis by synthetic peptides, carbohydrates and drugsExperimental inhibition of fibrillogenesis and neurotoxicity by amyloid-beta (abeta) and other disease-related peptides/proteins by plant extracts and herbal compoundsAlzheimer's diseaseModeling the polyglutamine aggregation pathway in Huntington's disease: from basic studies to clinical applicationsParkinson's diseaseHuman prion diseases: From kuru to variant Creutzfeldt-jakob diseaseAnimal prion diseases[beta](2)-Microglobulin amyloidosisSystemic AA amyloidosisFamilial amyloidotic polyneuropathy and transthyretinThe challenge of systemic immunoglobulin light-chain amyloidosis (AL).
Beschreibung:XVII, 648 S.
Ill., graph. Darst.
ISBN:9789400754157
978-94-007-5415-7